ETF Holdings Breakdown of AVXL

Stock NameAnavex Life Sciences Corp
TickerAVXL(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS0327973006
LEI549300K1I5L8COCQ8W36

News associated with AVXL

MetLife Investment Management LLC Has $496,000 Holdings in Anavex Life Sciences Corp. (NASDAQ:AVXL)
MetLife Investment Management LLC grew its holdings in shares of Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) by 14.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 46,177 shares of the biotechnology company’s stock after acquiring an additional 5,816 […] - 2025-05-06 08:01:07
AlphaQuest LLC Acquires Shares of 13,626 Anavex Life Sciences Corp. (NASDAQ:AVXL)
AlphaQuest LLC acquired a new stake in shares of Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 13,626 shares of the biotechnology company’s stock, valued at approximately $146,000. Several other hedge funds and […] - 2025-03-18 08:06:52
19,558 Shares in Anavex Life Sciences Corp. (NASDAQ:AVXL) Bought by Proficio Capital Partners LLC
Proficio Capital Partners LLC bought a new position in shares of Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) in the fourth quarter, HoldingsChannel.com reports. The institutional investor bought 19,558 shares of the biotechnology company’s stock, valued at approximately $210,000. Several other hedge funds and other institutional investors have also recently modified their holdings of […] - 2025-03-13 07:14:57
Y Intercept Hong Kong Ltd Buys New Position in Anavex Life Sciences Corp. (NASDAQ:AVXL)
Y Intercept Hong Kong Ltd purchased a new position in Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) during the 4th quarter, HoldingsChannel reports. The firm purchased 22,631 shares of the biotechnology company’s stock, valued at approximately $243,000. Other large investors also recently made changes to their positions in the company. Barclays PLC lifted its […] - 2025-03-05 10:19:04
Anavex Life Sciences (NASDAQ:AVXL) vs. Cortexyme (NASDAQ:CRTX) Financial Survey
Anavex Life Sciences (NASDAQ:AVXL – Get Free Report) and Cortexyme (NASDAQ:CRTX – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and profitability. Valuation & Earnings This table compares Anavex […] - 2025-02-28 07:00:47
HC Wainwright Reiterates Buy Rating for Anavex Life Sciences (NASDAQ:AVXL)
Anavex Life Sciences (NASDAQ:AVXL – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at HC Wainwright in a research note issued to investors on Tuesday,Benzinga reports. They presently have a $42.00 price target on the biotechnology company’s stock. HC Wainwright’s price objective would indicate a potential upside of 382.48% from the […] - 2025-02-20 07:14:43
Anavex Life Sciences Corp. (NASDAQ:AVXL) Shares Purchased by China Universal Asset Management Co. Ltd.
China Universal Asset Management Co. Ltd. boosted its holdings in shares of Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) by 10.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 17,980 shares of the biotechnology company’s stock after acquiring […] - 2025-02-04 09:46:55
SG Americas Securities LLC Has $374,000 Position in Anavex Life Sciences Corp. (NASDAQ:AVXL)
SG Americas Securities LLC lifted its stake in Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) by 25.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 34,844 shares of the biotechnology company’s stock after buying an additional 7,138 shares during the period. […] - 2025-02-04 08:55:00

AVXL institutional holdings

The following institutional investment holdings of AVXL have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-08 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 40,384USD 345,687
2025-05-08 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 40,384USD 345,687
2025-05-08 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 52,382USD 448,390
2025-05-08 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 35,934USD 307,595
2025-05-08 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 803USD 6,874
Total =169,887 USD 1,454,233
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.